Cite Filings / CADL / 0000950170-25-003300

Feed Companies Filings Check

Sign in

144

Sale of Securities

Candel Therapeutics, Inc. Filed 2025-01-08 Acc 0000950170-25-003300

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2025-01-10 4 Chief Technology Officer sold 14,545 shares at $8.22 ($119,534)
2025-01-10 4 Chief Medical Officer sold 10,799 shares at $8.22 ($88,749)
2025-01-08 144 Sale of Securities
2025-01-08 144 Sale of Securities
2025-01-08 144 Sale of Securities
2025-01-08 144 Sale of Securities
2025-01-08 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…